Clinical trial

A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasms

NCT00001444

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1995-08-01

PhasePHASE1

Study timeline

Study start (unknown)1995-08-01Date precision: month

Registry last updated2008-03-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Lymphomaunresolved

Neoplasmunresolved

Prostatic Neoplasmunresolved

Interventions

7-hydroxystaurosporine (UCN-01)DRUG

Sponsors & collaborators

National Cancer Institute (NCI)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00001444 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.